MeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 Signaling Pathways
Lingyu Zhao(Henan Normal University), Chen Huang(Xi'an Jiaotong University), Yingxun Liu(Xi'an Jiaotong University), Yannan Qin(Xi'an Jiaotong University), Yanke Chen(Xi'an Jiaotong University), Meng Xue(Sir Run Run Shaw Hospital), Na Liu(Weifang Medical University), Siyuan Liu(Delft University of Technology), Juan Yang(Xi'an Jiaotong University), Liying Liu(Xi'an Jiaotong University), Bo Guo(National University of Defense Technology), Jia Han(Shanghai Institute of Nutrition and Health), Ni Hou(Xi'an Jiaotong University), Ning Du(Sichuan Agricultural University), Dongdong Tong(Xi'an Jiaotong University), Xiaoge Zhao(Xi'an Jiaotong University), Lumin Wang(Second Affiliated Hospital of Xi'an Jiaotong University)
Cited by 82
Related Papers
Targeted Delivery of CRISPR/Cas9‐Mediated Cancer Gene Therapy via Liposome‐Templated Hydrogel Nanoparticles
|Advanced Functional Materials|2017|297
Chlorogenic acid induces reactive oxygen species generation and inhibits the viability of human colon cancer cells
|Anti-Cancer Drugs|2016|146
Charcoal records of fire history in the Holocene loess–soil sequences over the southern Loess Plateau of China
|Palaeogeography Palaeoclimatology Palaeoecology|2006|118
In vivo Imaging and Drug Storage by Quantum‐Dot‐Conjugated Carbon Nanotubes
|Advanced Functional Materials|2008|114